Basics Curis, Inc. Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge. IPO Date: August 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $21.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.57% Avg Daily Range (30 D): $0.09 | 4.76% Avg Daily Range (90 D): $0.09 | 3.98% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): .06M Avg Daily Volume (90 D): .05M Trade Size Avg Trade Size (Sh.): 264 Avg Trade Size (Sh.) (30 D): 218 Avg Trade Size (Sh.) (90 D): 198 Institutional Trades Total Inst.Trades: 635 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $.85M Avg Inst. Trade (90 D): $.85M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.21M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 16.78K         News Jul 11, 2024 @ 10:09 AM VISTA Inhibitor Clinical Trials Drug Approval Insi... Source: Kuick Research Apr 12, 2024 @ 12:34 PM Top 3 Health Care Stocks That May Collapse In Q2 Source: Avi Kapoor Apr 5, 2024 @ 12:43 PM Strength Seen in Curis (CRIS): Can Its 19.5% Jump ... Source: Zacks Equity Research Feb 9, 2024 @ 1:11 PM CyberArk Software To Rally Around 19%? Here Are 10... Source: Avi Kapoor Jan 24, 2024 @ 6:05 PM Why BlackBerry Shares Are Trading Lower By Over 17... Source: Avi Kapoor Financials   TTM Q1 2025 Q4 2024 Basic EPS $-6.09 $-1.25 $-1.11 Diluted EPS $-6.09 $-1.25 $-1.11 Revenue $ 11.2M $ 2.38M $ 3.35M Gross Profit $ $ $ Net Income / Loss $ -42.13M $ -10.62M $ -9.62M Operating Income / Loss $ -42.23M $ -10.16M $ -8.99M Cost of Revenue $ $ $ Net Cash Flow $ -9.96M $ M $ -.86M PE Ratio     Splits Sep 29, 2023:   1:20 May 30, 2018:   1:5